Stroke Code Presentations, Interventions, and Outcomes Before and During the COVID-19 Pandemic.
Aged
Aged, 80 and over
Betacoronavirus
Brain Ischemia
/ diagnosis
COVID-19
Cohort Studies
Comorbidity
Connecticut
/ epidemiology
Coronary Artery Disease
/ epidemiology
Coronavirus Infections
/ epidemiology
Dyslipidemias
/ epidemiology
Emergency Medical Services
Ethnicity
Female
Humans
Hypertension
/ epidemiology
Income
Insurance, Health
Intracranial Hemorrhages
/ diagnosis
Male
Medically Uninsured
Middle Aged
Outcome and Process Assessment, Health Care
Pandemics
Pneumonia, Viral
/ epidemiology
Retrospective Studies
SARS-CoV-2
Severity of Illness Index
Stroke
/ diagnosis
Substance-Related Disorders
/ epidemiology
Telemedicine
Thrombectomy
Thrombolytic Therapy
Time-to-Treatment
/ statistics & numerical data
coronavirus disease
pandemics
stroke
Journal
Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
7
8
2020
medline:
4
9
2020
entrez:
7
8
2020
Statut:
ppublish
Résumé
Anecdotal reports suggest fewer patients with stroke symptoms are presenting to hospitals during the coronavirus disease 2019 (COVID-19) pandemic. We quantify trends in stroke code calls and treatments at 3 Connecticut hospitals during the local emergence of COVID-19 and examine patient characteristics and stroke process measures at a Comprehensive Stroke Center (CSC) before and during the pandemic. Stroke code activity was analyzed from January 1 to April 28, 2020, and corresponding dates in 2019. Piecewise linear regression and spline models identified when stroke codes in 2020 began to decline and when they fell below 2019 levels. Patient-level data were analyzed in February versus March and April 2020 at the CSC to identify differences in patient characteristics during the pandemic. A total of 822 stroke codes were activated at 3 hospitals from January 1 to April 28, 2020. The number of stroke codes/wk decreased by 12.8/wk from February 18 to March 16 ( Hospital presentation for stroke-like symptoms decreased during the COVID-19 pandemic, without differences in stroke severity or early outcomes. Individuals living outside of the CSC city were less likely to present for stroke codes at the CSC during the pandemic. Public health initiatives to increase awareness of presenting for non-COVID-19 medical emergencies such as stroke during the pandemic are critical.
Sections du résumé
BACKGROUND
Anecdotal reports suggest fewer patients with stroke symptoms are presenting to hospitals during the coronavirus disease 2019 (COVID-19) pandemic. We quantify trends in stroke code calls and treatments at 3 Connecticut hospitals during the local emergence of COVID-19 and examine patient characteristics and stroke process measures at a Comprehensive Stroke Center (CSC) before and during the pandemic.
METHODS
Stroke code activity was analyzed from January 1 to April 28, 2020, and corresponding dates in 2019. Piecewise linear regression and spline models identified when stroke codes in 2020 began to decline and when they fell below 2019 levels. Patient-level data were analyzed in February versus March and April 2020 at the CSC to identify differences in patient characteristics during the pandemic.
RESULTS
A total of 822 stroke codes were activated at 3 hospitals from January 1 to April 28, 2020. The number of stroke codes/wk decreased by 12.8/wk from February 18 to March 16 (
CONCLUSIONS
Hospital presentation for stroke-like symptoms decreased during the COVID-19 pandemic, without differences in stroke severity or early outcomes. Individuals living outside of the CSC city were less likely to present for stroke codes at the CSC during the pandemic. Public health initiatives to increase awareness of presenting for non-COVID-19 medical emergencies such as stroke during the pandemic are critical.
Identifiants
pubmed: 32755347
doi: 10.1161/STR.0000000000000347
pmc: PMC7446978
mid: NIHMS1606892
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2664-2673Subventions
Organisme : NINDS NIH HHS
ID : K23 NS110980
Pays : United States
Organisme : NINR NIH HHS
ID : R01 NR018335
Pays : United States
Organisme : NINDS NIH HHS
ID : U24 NS107136
Pays : United States
Organisme : NINDS NIH HHS
ID : R03 NS112859
Pays : United States
Organisme : NINDS NIH HHS
ID : U24 NS107215
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS106513
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS110721
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NINDS NIH HHS
ID : T32 NS047996
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
BMJ. 2020 Apr 6;369:m1406
pubmed: 32253176
J Stroke Cerebrovasc Dis. 2019 Apr;28(4):1022-1026
pubmed: 30638938
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
J Am Heart Assoc. 2014 Dec 08;3(6):e001354
pubmed: 25488295
Circulation. 2009 Jan 6;119(1):107-15
pubmed: 19075103
Neurol Res. 2009 Nov;31(9):885-91
pubmed: 19138467
Stroke. 2012 Feb;43(2):560-2
pubmed: 22052513
Prehosp Disaster Med. 2015 Feb;30(1):80-8
pubmed: 25499440
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
N Engl J Med. 2020 Jul 23;383(4):400-401
pubmed: 32383831
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
J Thromb Haemost. 2020 May;18(5):1023-1026
pubmed: 32338827
J Med Virol. 2020 Jul;92(7):699-702
pubmed: 32314810
Am J Emerg Med. 2020 Jul;38(7):1504-1507
pubmed: 32317203
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
J Stroke Cerebrovasc Dis. 1993;3(1):3-8
pubmed: 26487072
Stroke. 2020 Jun;51(6):1910-1912
pubmed: 32233972